About Outset Medical
Outset Medical is a publicly listed company based in San Jose (United States) founded in 2003. Hemodialysis machines with touchscreen displays are provided for medical use. Outset Medical has raised $457.87 million across 10 funding rounds from investors including Fidelity Investments, T. Rowe Price and Baxter. Its website outsetmedical.com draws about 11 thousand monthly visits. Outset Medical offers products and services including Tablo Hemodialysis System. Its focus areas include Life Sciences, Nephrology, Medical Devices and Therapeutic Devices. Its legal entity is Outset Medical, Inc. Its competitors include Diality and NxStage; 1 of its 2 listed competitors has raised funding.
Company details
Outset Medical was established in 2003 in San Jose, United States, within the medical device sector. Hemodialysis solutions are developed and supplied by the company, with the Tablo system serving as the primary product. This machine incorporates a touchscreen interface that delivers step-by-step visual guidance and interactive prompts to facilitate dialysis procedures. Operations emphasize equipment for renal care, distributed across healthcare facilities in the region.
- Annual Revenue$119.48 M (USD)5.09as on Dec 31, 2025
- Net Profit-$81.65 M (USD)36.2as on Dec 31, 2025
- EBITDA-$62.37 M (USD)38.91as on Dec 31, 2025
- Total Equity Funding$457.87M (USD)
in 10 rounds
- Latest Funding Round$3.89M (USD), Post-IPO
Jan 2025
- InvestorsFidelity Investments
& 8 more
Products & Services of Outset Medical
Outset Medical offers a comprehensive portfolio of products and services, including Tablo Hemodialysis System.
All-in-one system for hemodialysis treatments in hospitals and homes.
Apps and channels of Outset Medical
its YouTube channel Outset Medical has 926 subscribers and 30 videos.
Videos from Outset Medical
The most watched videos on Outset Medical's YouTube channel, Outset Medical (926 subscribers). Click a video to play it here.
More on Outset Medical.
Funding Insights of Outset Medical
Outset Medical has successfully raised a total of $457.87M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $3.89 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $457.87M
- Total Rounds 10
- Last Round Post-IPO — $3.89M
- First Round $9.5M
(Feb 2011)
- Investors Count 9
All 10 funding rounds of Outset Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2025 | $3.89M | Post-IPO | – | – | – |
| Feb 2020 | $125M | Series E | – | – | |
| Aug 2018 | $132M | Series D | – | Mubadala | |
| Jun 2017 | $4.29M | Series C | – | – | – |
| May 2017 | $76.48M | Series C | – | T. Rowe Price | |
| Jun 2015 | $51M | Series B | – | – | |
| Jun 2015 | $40M | Debt – Venture | – | – | |
| May 2015 | $59.59M | Series B | – | Warburg Pincus, The Vertical Group | – |
| Feb 2011 | $9.5M | Unspecified | – | – | – |
| Feb 2011 | $9.5M | Series A | – | – | – |
9 investors in total: 9 institutional.
Investors in Outset Medical
Outset Medical has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, T. Rowe Price and Baxter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Healthcare companies are invested in by this private equity firm. | pfmhealthsciences.com | San Francisco, United States | ||
Multi-stage private equity investments are pursued across diverse sectors. | 1966 | warburgpincus.com | New York, United States | |
Investments in early and late-stage US companies are made. | vertical-group.com | Basking Ridge, United States | ||
CRG is recognized as a premier healthcare investment partner. | crglp.com | Houston, United States | ||
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | 1946 | fidelity.com | Boston, United States | |
Diversified asset management services are provided to investors globally. | 1937 | troweprice.com | Baltimore, United States | |
Sovereign wealth fund of United Arab Emirates | 2002 | mubadala.com | Abu Dhabi, United Arab Emirates | |
Biosciences, medication delivery, and renal products are developed and marketed. | 1931 | baxter.com | Deerfield, United States |
Investor details for Outset Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Outset Medical
109 people are tracked at Outset Medical (28 in leadership, 7 in board & advisors, 74 in team).
| Name | Role | Group |
|---|---|---|
Sara Stukes | Director Of Training | Leadership |
Asghar Alí | Senior Talent Acquisition Partner | Leadership |
Leslie Trigg | Chair & CEO | Leadership |
Jim Mazzola | Head, Investor Relations | Leadership |
Michael Aragon | Chief Medical Officer | Leadership |
Priya Viswanathan | Director, Regulatory Affairs | Leadership |
Amelia Merrill | VP, People Operations & Culture | Leadership |
Lisa Hertel | Sr. Director, Commercial Fp&a | Leadership |
Chris Snell | Market Director Southeast | Leadership |
Semion Gengrinovich | Director, Reliability Engineering & Field Analytics | Leadership |
Manish Khemani | Sr. Director, Hardware Engineering | Leadership |
Hector Vidal | Sr. Director Manufacturing / Plant Manager | Leadership |
Evin MacAluso | Vice President Of Sales | Leadership |
Jennifer Ralston | Director, Legal Affairs & Contracts | Leadership |
Brandon F. | Senior Director, Sales Enablement | Leadership |
Brett Fogg | Senior Vice President R&d And Operations | Leadership |
Angel Chow | Senior Director, Assistant Controller | Leadership |
Alonso Mendoza (Cmq/Oe | Sr Director, Quality Assurance | Leadership |
Tim Roth | Director Sales National Account | Leadership |
Jamal Ahsan | Sr Director Of Revenue | Leadership |
89 more people are available in the full profile.
Complete people profiles for Outset Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Outset Medical
Outset Medical is a publicly listed company on the NASDAQ with ticker symbol OM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Sep 2020
- Listed onNASDAQ: OM
- Listed entityOutset Medical, Inc.
- Exchange sectorHealth technology
- ISINUS6901452069
- Share price$4.06 (+1.25% on the day) · 2026-10-13
- Market capitalisation$76.2M
- EPS (diluted, trailing year)$-4.10
- Volume (last session)68,526
Financials of Outset Medical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $119.5M | -$81.7M | -$62.4M |
| 2024 | $113.7M | -$128.0M | -$102.1M |
| 2023 | $130.4M | -$172.8M | -$164.0M |
| 2022 | $115.4M | -$163.0M | -$154.7M |
| 2021 | $102.6M | -$131.9M | -$124.3M |
Detailed financial statements for Outset Medical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Outset Medical
4 dated milestones of Outset Medical across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Outset Medical is founded.
- Funding First funding round of $9.5M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $3.9M.
Competitors of Outset Medical
Outset Medical has 2 listed competitors in our database, 1 of them funded. They include Diality and NxStage.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| diality.com | 2013 | Irvine, United States | $82.5M | 40 | Developer of portable hemodialysis device | |
| nxstage.com | 1998 | Lawrence, United States | 732 | Home and critical care dialysis systems |
Detailed competitors of Outset Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Outset Medical
The website of Outset Medical (outsetmedical.com) receives about 10.7K visits a month.
- Monthly visits10.7K
▲ 22.2% vs previous month
Websites whose visitors overlap most with Outset Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dotmed.com | 100% | #118,835 | View details | ||
| massdevice.com | 99% | #435,992 | View details | ||
medtechdive.com | medtechdive.com | 99% | #345,845 | – | |
| kidneycareuk.org | 69% | #317,410 | View details | ||
| seasonhealth.com | 62% | 170.1K | #273,806 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Outset Medical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nephrology
3 companies that operate in the same segment as Outset Medical (Nephrology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for kidney disease treatment are developed by Akebia Therapeutics. | 2007 | Cincinnati, Ohio, United States | USD 91 M | USD 236.2 M | 181 | |
Developer of portable hemodialysis device | 2013 | Irvine, California, United States | USD 82.5 M | 40 | ||
Small molecule therapies for kidney diseases are developed. | 2016 | San Francisco, California, United States | USD 1.55 M | 22 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Outset Medical
Complete news archive for Outset Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Outset Medical
Outset Medical was founded in 2003 and raised its 1st funding round 8 years after it was founded.
Outset Medical is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Outset Medical is a funded company, having raised a total of $457.87M across 10 funding rounds to date. The company's 1st funding round was a Series A of $9.5M, raised on Feb 2011.
Annual revenue of Outset Medical is $119.48M as on Dec 31, 2025.
Outset Medical was established in 2003 in San Jose, United States, within the medical device sector. Hemodialysis solutions are developed and supplied by the company, with the Tablo system serving as the primary product. This machine incorporates a touchscreen interface that delivers step-by-step visual guidance and interactive prompts to facilitate dialysis procedures. Operations emphasize equipment for renal care, distributed across healthcare facilities in the region.
Outset Medical offers Tablo Hemodialysis System.
Yes, Outset Medical is publicly traded on NASDAQ under the ticker symbol OM.
Outset Medical has 9 investors. Key investors include Fidelity Investments, T. Rowe Price, Baxter, Mubadala, and Warburg Pincus.
Outset Medical operates through Outset Medical, Inc..